Frankfurt - Delayed Quote EUR
Geron Corporation (GON.F)
1.1860
-0.0340
(-2.79%)
As of 8:10:13 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
AGGARWAL GAURAV Director | Stock Award(Grant) | Dec 29, 2023 | 1,970 |
FELLER FAYE Officer | Conversion of Exercise of derivative security | Jun 10, 2024 | 0 |
GRETHLEIN ANDREW J Chief Operating Officer | Conversion of Exercise of derivative security | Jul 8, 2024 | 0 |
KAPUR ANIL Officer | Conversion of Exercise of derivative security | Jun 10, 2024 | 0 |
LAWLIS VIRGIL BRYAN JR. Director | Conversion of Exercise of derivative security | May 15, 2024 | 0 |
MOLINEAUX SUSAN M Director | Stock Award(Grant) | Dec 29, 2023 | -- |
SAMUELS SCOTT ALAN Officer | Purchase | Feb 27, 2025 | 26,682 |
SCARLETT JOHN A Chief Executive Officer | Purchase | Feb 27, 2025 | 137,500 |
SPIEGEL ROBERT J Director | Stock Award(Grant) | Mar 31, 2025 | 177,304 |
ZIEGLER JAMES Officer | Purchase | Feb 27, 2025 | 100,000 |
Related Tickers
UR8.BE UroGen Pharma Ltd. R
10.00
-1.96%
I9SA.F Verona Pharma plc
62.60
+0.64%
ZH6.BE Biohaven Ltd. R
20.40
+0.99%
49BA.BE BeiGene Ltd
222.00
0.00%
TENX Tenax Therapeutics, Inc.
5.77
+3.13%
PTCT PTC Therapeutics, Inc.
49.95
+0.87%
NUVB Nuvation Bio Inc.
2.4600
+8.37%
ALLO Allogene Therapeutics, Inc.
1.7000
+0.59%
MAIA MAIA Biotechnology, Inc.
2.0500
-17.34%
SLS SELLAS Life Sciences Group, Inc.
1.7400
+7.41%